ScienceDaily: Mind & Brain News

'Think twice' campaign could reduce risk of UK opioid epidemic. A pilot campaign that urged GPs (family doctors) to 'think-twice' before putting a patient on opioid medicines was effective in reducing opioid prescribing in primary care, according to the findings of a major study. Although the reduction in the number of opioid prescriptions issued by individual GPs was small, when aggregated together they had a large effect.

As the pandemic grinds on through a second year, many American workers are feeling the pressure, and many say they intend to leave their jobs within a year, according to a new survey.

A brain circuit that works as a 'brake' on binge alcohol drinking may help explain male-female differences invulnerability to alcohol use disorders, according to a preclinical study.

Physicians have successfully treated a patient with severe depression by tapping into the specific brain circuit involved in depressive brain patterns and resetting them using the equivalent of a pacemaker for the brain.

A new study examined the development of a glioblastoma cancerous tumor in animal models with a normal immune system, in order to best simulate the development of the tumor in humans.

Reactive electrophilic drugs like Tecfidera, approved for the treatment of relapsing multiple sclerosis, show a lot of potential but are also mystery. Scientists have now used an innovative chemical method to uncover the biological mechanisms of Tecfidera, providing a powerful tool for exploring other reactive electrophilic drugs.

A new study shows evidence that the E2 gene is associated with a slower rate of cognitive decline with age.

Researchers have identified key changes in gene expression and structure in the developing human brain that makes it unique among all animal species.